|
|
||||||||
From the Veterans Affairs Medical Center (Drs. Green and Kaye) and the Departments of Neurology (Drs. Green, Kaye, and Ball) and Pathology (Dr. Ball), Oregon Health Sciences University, Portland, OR.
Address correspondence and reprint requests to Dr. Jeffrey Kaye, Oregon Health Sciences University, Mail Drop CR-131, 3181 SW Sam Jackson Park Rd., Portland, OR 97201-3098; e-mail: greens{at}ohsu.edu
OBJECTIVE: To describe the relationship between neuropathologic aging and longitudinal measures of cognitive function in healthy oldest old individuals.
METHODS: Nondemented individuals without cardiovascular or other age-associated diseases of age
85 years were followed until death. Regional postmortem measures of senile plaque (SP) and neurofibrillary tangle (NFT) severity were examined in relationship to clinical status, cognitive measures, and rate of cognitive change.
RESULTS: Among 19 healthy individuals, 10 became demented or had incipient dementia develop. Clinical status and rate of change in cognitive scores correlated with increasing brain lesion burden, particularly in neocortical regions. Compared to demented individuals, nondemented individuals had few or no neocortical NFT (p = 0.009) or SP (p = 0.001). There was a strong correlation between rate of cognitive change on Mini-Mental State Examination (MMSE) and neocortical NFT (r = 0.859, p = 0.001). The few NFT and SP in nondemented patients had a predilection for limbic areas.
CONCLUSIONS: These results support a continuum in which AD is infrequent in the healthy, cognitively stable, oldest old. The minimal abnormalities in cognitively stable individuals are consistent with the notion that preclinical pathologic AD precedes obvious cognitive impairment. Longitudinal cognitive testing shows an increased burden of neuropathologic changes in those who have cognitive decline but are not functionally impaired and do not meet criteria for the diagnosis of dementia. The strong relationship between cumulative pathologic changes and rate of cognitive decline suggests that these lesions may have clinical consequences at any age and are not likely to be benign senescent changes.
Key words: AgingNeuropathologyDementiaCognition
This article has been cited by other articles:
![]() |
G. M. Savva, S. B. Wharton, P. G. Ince, G. Forster, F. E. Matthews, C. Brayne, and the Medical Research Council Cognitive Function an Age, Neuropathology, and Dementia N. Engl. J. Med., May 28, 2009; 360(22): 2302 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Erten-Lyons, R. L. Woltjer, H. Dodge, R. Nixon, R. Vorobik, J. F. Calvert, M. Leahy, T. Montine, and J. Kaye Factors associated with resistance to dementia despite high Alzheimer disease pathology Neurology, January 27, 2009; 72(4): 354 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Weiner Expanding ventricles may detect preclinical Alzheimer disease Neurology, March 11, 2008; 70(11): 824 - 825. [Full Text] [PDF] |
||||
![]() |
N. E. Carlson, M. M. Moore, A. Dame, D. Howieson, L. C. Silbert, J. F. Quinn, and J. A. Kaye Trajectories of brain loss in aging and the development of cognitive impairment Neurology, March 11, 2008; 70(11): 828 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, V. J. Lowe, M. L. Senjem, S. D. Weigand, B. J. Kemp, M. M. Shiung, D. S. Knopman, B. F. Boeve, W. E. Klunk, C. A. Mathis, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain, March 1, 2008; 131(3): 665 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bennett, J. A. Schneider, Z. Arvanitakis, J. F. Kelly, N. T. Aggarwal, R. C. Shah, and R. S. Wilson Neuropathology of older persons without cognitive impairment from two community-based studies Neurology, June 27, 2006; 66(12): 1837 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Peters Ageing and the brain Postgrad. Med. J., February 1, 2006; 82(964): 84 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Prohovnik, D. P. Perl, K. L. Davis, L. Libow, G. Lesser, and V. Haroutunian Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease Neurology, January 10, 2006; 66(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bennett, J. A. Schneider, R. S. Wilson, J. L. Bienias, and S. E. Arnold Neurofibrillary Tangles Mediate the Association of Amyloid Load With Clinical Alzheimer Disease and Level of Cognitive Function Arch Neurol, March 1, 2004; 61(3): 378 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.C. Silbert, J.F. Quinn, M.M. Moore, E. Corbridge, M.J. Ball, G. Murdoch, G. Sexton, and J.A. Kaye Changes in premorbid brain volume predict Alzheimer's disease pathology Neurology, August 26, 2003; 61(4): 487 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marquis, M. M. Moore, D. B. Howieson, G. Sexton, H. Payami, J. A. Kaye, and R. Camicioli Independent Predictors of Cognitive Decline in Healthy Elderly Persons Arch Neurol, April 1, 2002; 59(4): 601 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr., D. W. Dickson, J. E. Parisi, Y. C. Xu, R. H. Cha, P. C. O'Brien, S. D. Edland, G. E. Smith, B. F. Boeve, E. G. Tangalos, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia Neurology, March 12, 2002; 58(5): 750 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, G. Ratcliff, S. H. Belle, J. A. Cauley, S. T. DeKosky, and M. Ganguli Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease: A Prospective Community Study Arch Gen Psychiatry, September 1, 2001; 58(9): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. McNeal, S. Zareparsi, R. Camicioli, A. Dame, D. Howieson, J. Quinn, M. Ball, J. Kaye, and H. Payami Predictors of Healthy Brain Aging J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2001; 56(7): B294 - 301. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |